248 related articles for article (PubMed ID: 15925528)
1. [Apheresis donation. Current views and perspectives].
Schooneman F
Transfus Clin Biol; 2005 Jun; 12(2):208-11. PubMed ID: 15925528
[No Abstract] [Full Text] [Related]
2. Stem cell transfusion.
Hervé P
Transfus Sci; 1992; 13(4):373-4. PubMed ID: 10150137
[No Abstract] [Full Text] [Related]
3. The donor of blood and its components.
Högman CF
Schweiz Med Wochenschr Suppl; 1991; 43():111-4. PubMed ID: 1843033
[No Abstract] [Full Text] [Related]
4. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
[TBL] [Abstract][Full Text] [Related]
5. Transfusion and Apheresis Science. Editorial 38.2.
Rock G
Transfus Apher Sci; 2008 Apr; 38(2):89. PubMed ID: 18400559
[No Abstract] [Full Text] [Related]
6. Complications of donor apheresis.
Winters JL
J Clin Apher; 2006 Jul; 21(2):132-41. PubMed ID: 15880355
[TBL] [Abstract][Full Text] [Related]
7. [Labile blood products and their preparation].
Chabanel A; Folléa G
Rev Prat; 2001 Jun; 51(12):1306-10. PubMed ID: 11503503
[TBL] [Abstract][Full Text] [Related]
8. Thrombin generation before and after multicomponent blood collection.
Cimenti C; Sipurzynski S; Gallistl S; Rosenkranz A; Hiden M; Leschnik B; Schallmoser K; Lanzer G; Muntean WE
Transfusion; 2008 Aug; 48(8):1584-90. PubMed ID: 18503617
[TBL] [Abstract][Full Text] [Related]
9. [Blood component therapy today].
Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Sirchia G
Haematologica; 1991 Jun; 76 Suppl 3():405-10. PubMed ID: 1752540
[No Abstract] [Full Text] [Related]
10. Innovations in blood donor screening and blood collection.
Smith JW; Forsberg JE; Gilcher RO
Curr Hematol Rep; 2002 Nov; 1(2):129-33. PubMed ID: 12901134
[TBL] [Abstract][Full Text] [Related]
11. [Blood components: indication and notice of transfusion].
Sekiguchi S
Nihon Rinsho; 1997 Sep; 55(9):2205-13. PubMed ID: 9301278
[TBL] [Abstract][Full Text] [Related]
12. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques.
Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C
J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261
[TBL] [Abstract][Full Text] [Related]
13. The quality of blood products in Mississippi takes another leap forward.
Jett PL
J Miss State Med Assoc; 1999 Nov; 40(11):390-1. PubMed ID: 10568090
[No Abstract] [Full Text] [Related]
14. Current trends in blood component therapy: the evolution of a safer, more effective product.
Baranowski L
J Intraven Nurs; 1992; 15(3):136-51. PubMed ID: 1608013
[TBL] [Abstract][Full Text] [Related]
15. Bio- (hemo- plus eco-) compatibility of blood collection- and apheresis harness.
Nydegger UE
Beitr Infusionsther; 1991; 28():152-8. PubMed ID: 1725613
[No Abstract] [Full Text] [Related]
16. Bedside processing.
Krause KP
Vox Sang; 2004 Jul; 87 Suppl 2():76-8. PubMed ID: 15209884
[No Abstract] [Full Text] [Related]
17. [Multiple apheresis].
Coffe C
Transfus Clin Biol; 2007 May; 14(1):86-9. PubMed ID: 17521944
[TBL] [Abstract][Full Text] [Related]
18. The six questions of pathogen reduction technology: an overview of current opinions.
Solheim BG; Seghatchian J
Transfus Apher Sci; 2008 Aug; 39(1):51-7. PubMed ID: 18614401
[TBL] [Abstract][Full Text] [Related]
19. International forum--the "6 Pillars" of best practice in apheresis technologies: introductory remarks.
de Sousa G; Seghatchian J
Transfus Apher Sci; 2006 Feb; 34(1):107-23. PubMed ID: 16448850
[No Abstract] [Full Text] [Related]
20. Bacterial contamination of cellular blood components: risks, sources and control.
Blajchman MA
Vox Sang; 2004 Jul; 87 Suppl1():98-103. PubMed ID: 15200616
[No Abstract] [Full Text] [Related]
[Next] [New Search]
